Author:
Ito Y.,Narimatsu H.,Fukui T.,Fukao A.,Yoshioka T.
Reference17 articles.
1. New sources of drugs for hematologic malignancies;Sukhai;Blood,2011
2. Review process of anticancer drugs in Japan;Hori;The Japanese Journal of Clinical Hematology,2006
3. Hurry up and wait: is accelerated approval of new cancer drugs in the best interests of cancer patients?;Schilsky;J Clin Oncol,2003
4. European Medicines Agency: Assessment report of tepadina from European Medicines Agencyhttp://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/001046/WC500090255.pdf (11 October 2012, date last accessed)
5. Critical review of the determination process by the Japanese Reviewing Authority in approving the additional efficacy of fludarabine phosphate;Narimatsu;J Clin Oncol,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献